What is Respiree?
Respiree is at the forefront of health technology, specializing in the development of clinically-validated artificial intelligence (AI) and machine learning (ML) solutions designed to manage disease progression across the healthcare continuum. The company's proprietary 1Bio platform leverages data from Electronic Health Records (EHR) and its own US-patented, FDA-cleared sensors to provide longitudinal measurement and tracking of disease progression. With a presence now established in the U.S., Australia, and the Asia-Pacific (APAC) region, Respiree is making significant strides in improving patient outcomes through data-driven insights.
How much funding has Respiree raised?
Respiree has raised a total of $11.6M across 1 funding round:
Series A
$11.6M
Series A (2025): $11.6M with participation from SEEDS Capital, ClavystBio, She1K, and Greenwillow Capital Management
Key Investors in Respiree
SEEDS Capital
SEEDS Capital, a Singapore government agency, focuses on catalyzing investments into early-stage technology startups, employing a co-investment model to support deep tech across various sectors including health sciences. They aim to partner with investors to foster innovation and growth.
ClavystBio
ClavystBio is a life sciences investor and venture builder dedicated to translating scientific breakthroughs into health impacts, actively incubating and investing in global companies within the sector.
She1K
she1K connects corporate executive women globally to foster innovative entrepreneurship with high growth potential, emphasizing diversity and providing a platform for networking and investment in startups.
What's next for Respiree?
This substantial enterprise-level funding, particularly the recent strategic investment, signals a pivotal growth phase for Respiree. The capital infusion is expected to fuel further research and development, enhance the capabilities of the 1Bio platform, and expand the company's market reach. Respiree is strategically positioned to capitalize on the growing demand for AI-driven healthcare solutions, aiming to solidify its leadership in disease progression management and further integrate its technology into global healthcare systems.
See full Respiree company page
